Filing search / Kineta, Inc. / "Recoup"

8-K

EX-99.5

KANT Kineta, Inc.

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

, if any, Kineta is able to generate from the sale of the product in that country. Adverse pricing limitations may hinder Kineta’s ability to recoup its

424B3

KANT Kineta, Inc.

10 Nov 22

Prospectus supplement

4:21pm

ability to recoup its investment in one or more product candidates, even if such product candidates obtain marketing approval. Reimbursement

S-4

EX-10.16

roqj6f 9mcr

23 Sep 20

Registration of securities issued in business combination transactions

4:50pm